Human Gut Microbiota Changes Reveal the Progression of Glucose Intolerance

Xiuying Zhang, Dongqian Shen, Zhiwei Fang, Zhuye Jie, Xinmin Qiu, Chunfang Zhang, Yingli Chen, Linong JiPLoS 2013 · DOI

Abstract

To explore the relationship between gut microbiota and the development of type 2 diabetes (T2DM), this study analyzed 121 subjects categorized by glucose intolerance status: normal glucose tolerance (NGT), prediabetes (Pre-DM), and newly diagnosed T2DM. Using 16S rDNA-based high-throughput sequencing, researchers observed T2DM-related dysbiosis, including distinct microbial community separation and shifts in alpha diversity. Significant associations were found between metabolic parameters (FPG, CRP) and gut microbiota structure. Notably, beneficial butyrate-producing bacteria were more abundant in healthy subjects, while Bacteroides levels were halved in the T2DM group. These findings suggest that structural modulation of the gut microbiota is an early event in the pathogenesis of diabetes.

Introduction

While genetics and lifestyle are established drivers of Type 2 Diabetes (T2DM), the gut microbiome—the complex ecosystem of trillions of bacteria in the digestive tract—has emerged as a critical contributor to metabolic health. Most existing research focuses on the microbiome after a T2DM diagnosis has already been made. This study investigates the "dynamic development" of the disease, comparing healthy individuals (NGT), those with prediabetes (Pre-DM), and newly diagnosed diabetics to determine if gut alterations are a consequence of the disease or an early warning sign appearing during the progression of glucose intolerance.

Methods

The study involved 121 subjects in Beijing, China, divided into three groups based on WHO criteria: NGT (n=44), Pre-DM (n=64), and T2DM (n=13).

  • Sequencing: High-throughput 16S rDNA sequencing (targeting the V3–V5 regions) was performed on fecal samples.
  • Bioinformatics: Data were processed using Mothur for noise reduction and CD-HIT for clustering into Operational Taxonomic Units (OTUs) at 97% similarity.
  • Statistical Analysis: Alpha diversity was measured using Chao1 and Shannon indices. Co-inertia Analysis (CIA) and PERMANOVA were employed to correlate microbial clusters with clinical markers like fasting plasma glucose (FPG) and C-reactive protein (CRP).

Results and Discussion

Microbial Community Shifts and Dysbiosis

The study revealed that microbial "dysbiosis"—a breakdown in the balance of the gut community—begins as early as the prediabetic stage. Co-inertia Analysis (CIA) demonstrated a separation of microbial communities across the three groups, with specific genera like Prevotella, Roseburia, and Bacteroides driving these shifts.

Co-inertia Analysis (CIA) plot showing the separation of microbial communities and the influence of specific bacterial genera across NGT, Pre-DM, and T2DM groups.

Diversity and Metabolic Health

A clear trend was observed in microbial diversity. As glucose intolerance progressed, overall diversity tended to decrease. Specifically, a negative correlation was found between fasting insulin (FINS) levels and the Chao1 diversity index, suggesting that insulin resistance is associated with a less diverse and potentially more fragile gut ecosystem.

Alpha diversity indices (Shannon and Chao1) across the three study groups, illustrating the trend of shifting microbial richness and evenness during the progression of glucose intolerance.

Key Biomarkers and Butyrate Production

Healthy (NGT) individuals exhibited significantly higher levels of beneficial butyrate-producing bacteria, such as Akkermansia muciniphila and Faecalibacterium prausnitzii. Butyrate is a short-chain fatty acid known for its anti-inflammatory properties and its role in maintaining gut barrier integrity. Conversely, the abundance of Bacteroides in the T2DM group was only half that of the NGT and Pre-DM groups. The class Verrucomicrobiae was also identified as a potential biomarker, showing significantly lower abundance in both Pre-DM and T2DM groups.

Conclusion

This research provides evidence that the structural modulation of gut microbiota is an early event in the progression toward Type 2 Diabetes. The loss of beneficial, butyrate-producing bacteria and the overall decline in microbial diversity during the prediabetic stage suggest that the microbiome could serve as a diagnostic tool for early intervention. While limited by a small T2DM sample size and a cross-sectional design, these findings underscore the importance of the gut-metabolism axis in human health.

Summary updated

Abstract

To explore the relationship of gut microbiota with the development of type 2 diabetes (T2DM), we analyzed 121 subjects who were divided into 3 groups based on their glucose intolerance status: normal glucose tolerance (NGT; n = 44), prediabetes (Pre-DM; n = 64), or newly diagnosed T2DM (n = 13). Gut microbiota characterizations were determined with 16S rDNA-based high-throughput sequencing. T2DM-related dysbiosis was observed, including the separation of microbial communities and a change of alpha diversity between the different glucose intolerance statuses. To assess the correlation between metabolic parameters and microbiota diversity, clinical characteristics were also measured and a significant association between metabolic parameters (FPG, CRP) and gut microbiota was found. In addition, a total of 28 operational taxonomic units (OTUs) were found to be related to T2DM status by the Kruskal-Wallis H test, most of which were enriched in the T2DM group. Butyrate-producing bacteria (e.g. Akkermansia muciniphila ATCCBAA-835, and Faecalibacterium prausnitzii L2-6) had a higher abundance in the NGT group than in the pre-DM group. At genus level, the abundance of Bacteroides in the T2DM group was only half that of the NGT and Pre-DM groups. Previously reported T2DM-related markers were also compared with the data in this study, and some inconsistencies were noted. We found that Verrucomicrobiae may be a potential marker of T2DM as it had a significantly lower abundance in both the pre-DM and T2DM groups. In conclusion, this research provides further evidence of the structural modulation of gut microbiota in the pathogenesis of diabetes.
BibTeX
@inproceedings{zhang2013human,
  author = {Xiuying Zhang and Dongqian Shen and Zhiwei Fang and Zhuye Jie and Xinmin Qiu and Chunfang Zhang and Yingli Chen and Linong Ji},
  title = {{Human Gut Microbiota Changes Reveal the Progression of Glucose Intolerance}},
  booktitle = {PLoS},
  year = {2013},
  doi = {10.1371/journal.pone.0071108},
}
Figure